EquityFlowCompanies › Huma Therapeutics

Huma Therapeutics

Healthtech · London, GB

AI digital health platform for patient engagement and remote monitoring.

Funding history

DateRoundAmount
Jul 2024Series D Plus
Digital-health company Huma Therapeutics closed an $80M Series D with AstraZeneca, Hitachi Ventures and Leaps by Bayer, and launched its Huma Cloud platform.
$80M

Investors

AstraZenecaHitachi VenturesLeaps by Bayer

Similar companies in Healthtech

Explore funding flow on EquityFlow →